Skip to main content

Advertisement

Log in

Hypertension risk in idiopathic hyperCKemia

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Patients with idiopathic hyperCKemia are usually reassured and discharged. However, these subjects may have increased hypertension risk, based on data from our population study, which showed that the population tertile with the highest serum creatine kinase activities had the highest systolic and diastolic blood pressure levels. Therefore, we assessed whether subjects with idiopathic hyperCKemia have greater occurrence of hypertension than controls.

We included 46 participants aged 18 to 67 years, diagnosed with idiopathic hyperCKemia at the departments of Neurology of the Universities of Amsterdam and Utrecht, The Netherlands. We found that 48% of the subjects with idiopathic hyperCKemia were hypertensive, as compared to 19% of the random population controls (n = 22,612, aged 20 to 65 years), an odds ratio of 3.9 (95 % CI, 2.2 to 6.9) before, and 2.0 (1.1 to 3.8) after adjustment for sex, age, and body mass index.

In accord with our previous finding of an association between creatine kinase and blood pressure in the general population, the data reported here suggest that subjects with idiopathic hyperCKemia have greater hypertension risk than controls. This may be due to relatively high tissue creatine kinase activity, resulting in greater ATP buffer capacity to create and sustain high blood pressure levels.

Larger, prospective studies are needed to further assess this association, but as active case finding is important in the diagnosis of hypertension, subjects with idiopathic hyperCKemia should be screened and monitored for the presence of hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. American Heart Association (2006) Heart Disease and Stroke Statistics – 2006 Update. Dallas, Texas: American Heart Association

  2. Apple FS, Rogers MA, Casal DC, Lewis L, Ivy JL, Lampe JW (1987) Skeletal muscle creatine kinase MB alterations in women marathon runners. Eur J Appl Physiol Occup Physiol. 56:49–52

    Article  PubMed  CAS  Google Scholar 

  3. Bannwarth B (2002) Drug-induced myopathies. Expert Opin Drug Saf 1:65–70

    Article  PubMed  CAS  Google Scholar 

  4. Brewster LM, de Visser M (1988) Persistent hyperCKemia: fourteen patients studied in retrospect. Acta Neurol Scand 77:60–63

    PubMed  CAS  Google Scholar 

  5. Brewster LM, Clark JF, van Montfrans GA (2000) Is greater tissue activity of creatine kinase the genetic factor increasing hypertension risk in black persons of sub-Saharan African descent? J Hypertension 18:1537–1544

    Article  CAS  Google Scholar 

  6. Brewster LM, Volger S, Clark JF, van Bavel E, Wolf H, van Montfrans GA (2005) Maximal contractions in resistance arteries of normotensive black and white women. J Hypertension 23:S15

    Google Scholar 

  7. Brewster LM, Taherzadeh Z, Clark JF, van Bavel E, Wolf H, van Montfrans GA (2006) Contraction in human resistance arteries depends on creatine kinase. J Hypertension 24:S403

    Article  Google Scholar 

  8. Brewster LM,Mairuhu G, Bindraban NR,Koopmans RP, Clark JF, van Montfrans GA (2006) Creatine kinase activity is associated with blood pressure. Circulation 114:2034–2039

    Article  PubMed  CAS  Google Scholar 

  9. Clark, JF (1994) The creatine kinase system in smooth muscle. Mol Cell Biochem 133–134:221–232

    Article  PubMed  Google Scholar 

  10. D'Adda E, Sciacco M, Fruguglietti ME, Crugnola V, Lucchini V, Martinelli- Boneschi F, Zecca C, Lamperti C, Comi GP, Bresolin N, Moggio M, Prelle A (2006) Follow-up of a large population of asymptomatic/oligosymptomatic hyperckemic subjects. J Neurol 253:1399–1403

    Article  PubMed  Google Scholar 

  11. De Sousa E, Veksler V, Bigard X, Mateo P, Ventura-Clapier R (2000) Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation 102:1847–1853

    PubMed  CAS  Google Scholar 

  12. Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 290:199–206

    Article  PubMed  Google Scholar 

  13. Hernelahti M, Tikkanen HO, Karjalainen J, Kujala UM (2005) Muscle fiber-type distribution as a predictor of blood pressure: a 19-year follow-up study. Hypertension 45:1019–1023

    Article  PubMed  CAS  Google Scholar 

  14. Hofman A, de Jong PT, van Duijn CM, Breteler MM (2006) Epidemiology of neurological diseases in elderly people: what did we learn from the Rotterdam Study? Lancet Neurol 5:545–550

    Article  PubMed  Google Scholar 

  15. Houweling ST, Kleefstra N, Lutgers HL, Groenier KH, Meyboom-de Jong B, Bilo HJ (2006) Pitfalls in blood pressure measurement in daily practice. Fam Pract 23:20–27

    Article  PubMed  CAS  Google Scholar 

  16. Imai Y, Watanabe N, Hashimoto J, Nishiyama A, Sakuma H, Sekino H, Omata K, Abe K (1995) Muscle cramps and elevated serum creatine phosphokinase levels induced by beta-adrenoceptor blockers. Eur J Clin Pharmacol 48(1):29–34

    Article  PubMed  CAS  Google Scholar 

  17. Iyengar MR (1984) Creatine kinase as an intracellular regulator. J Muscle Res Cell Motil 5:527–534

    Article  PubMed  CAS  Google Scholar 

  18. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC (1997) Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 99:1873–1879

    PubMed  CAS  Google Scholar 

  19. Oostenbroek RJ, Willems GM, Boumans ML, Soeters PB, Hermens WT (1985) Liver damage as a potential source of error in the estimation of myocardial infarct size from plasma creatine kinase activity. Cardiovasc Res 19:113–119

    Article  PubMed  CAS  Google Scholar 

  20. Reijneveld JC, Notermans NC, Linssen WH, Wokke JH (2000) Benign prognosis in idiopathic hyper-CK-emia. Muscle Nerve 23:575–579

    Article  PubMed  CAS  Google Scholar 

  21. Rowland LP, Willner J, Cerri C, Di- Mauro S, Miranda A (1980) Approaches to the membrane theory of Duchenne muscular dystrophy. In: Angelini C, Danieli GA, Fontanari D (eds) Muscular dystrophy research: advances and new trends.Amsterdam: Excerpta Medica, pp 3–13

  22. Schelleman H,Klungel OH,Kromhout D, de Boer A, Stricker BH,Verschuren WM (2004) Prevalence and determinants of undertreatment of hypertension in the Netherlands. J Hum Hypertens 18:317–324

    Article  PubMed  CAS  Google Scholar 

  23. Schlesselmann, JJ (1982) Case-control studies.New York: Oxford University Press, pp 5–26

    Google Scholar 

  24. Schumann G, Bonora R, Ceriotti F, Clerc-Renaud P, Ferrero CA, Ferard G, Franck PF, Gella FJ, Hoelzel W, Jorgensen PJ, Kanno T, Kessne A, Klauker R, Kristiansen N, Lessinger JM, Linsinger TP, Misaki H, Panteghini M, Pauwels J, Schimmel HG, Vialle A, Weidemann G, Siekmann L (2002) IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C Part 2. Reference procedure for the measurement of catalytic concentration of creatine kinase. Clin Chem Lab Med 40:635–642

    Article  PubMed  CAS  Google Scholar 

  25. Suarez-Kurtz G, Eastwood AB (1981) Release of sarcoplasmic enzymes from frog skeletal muscle. Am J Physiol 241:C98–C105

    PubMed  CAS  Google Scholar 

  26. Tiidus PM (2005) Can oestrogen influence skeletal muscle damage, inflammation, and repair? Br J Sports Med 39:251–253

    Article  PubMed  CAS  Google Scholar 

  27. Wallimann T, Dolder M, Schlattner U, Eder M, Hornemann T, O'Gorman E, Ruck A, Brdiczka D (1998) Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology. Biofactors 8:229–234

    PubMed  CAS  Google Scholar 

  28. Wong ET, Cobb C,Umehara MK,Wolff GA,Haywood LJ,Greenberg T, Shaw ST (1983) Heterogeneity of serum creatine kinase activity among racial and gender groups of the population. Am J Clin Pathol 79:582–586

    PubMed  CAS  Google Scholar 

  29. Wu G,Morris SM (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336:1–17

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. M. Brewster MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brewster, L.M., van Bree, S., Reijneveld, J.C. et al. Hypertension risk in idiopathic hyperCKemia. J Neurol 255, 11–15 (2008). https://doi.org/10.1007/s00415-008-0651-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0651-y

Key words

Navigation